Articles

Ending the runaround with RNA

Earlham Institute and NEB tackle challenging RNA with new library prep kit
Written byMel J. Yeates
| 3 min read

IPSWICH, Mass. & NORWICH, U.K.—The Earlham Institute, a life-sciences research institute, can sometimes face unique problems raised through the sheer breadth of biological samples that it works with. Samples the institute processes can come from any number of species of plant, animal or microbial organism. Certain plant species can be particularly challenging due to the inherent nature of nucleic acids that are extracted, specifically RNA that is used for next-generation sequencing (NGS) applications. Processing these samples has been problematic, and commercially available approaches have fallen short of producing high-quality libraries from particular species, thus limiting scientists’ ability to study them.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Published In

Volume 13 - Issue 8 | August 2017

August 2017

August 2017 Issue

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue